Article Text

other Versions

PDF
Original article
Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer
  1. J A M G Tol1,
  2. J E van Hooft2,
  3. R Timmer3,
  4. F J G M Kubben4,
  5. E van der Harst5,
  6. I H J T de Hingh6,
  7. F P Vleggaar7,
  8. I Q Molenaar8,
  9. Y C A Keulemans9,
  10. D Boerma10,
  11. M J Bruno11,
  12. E J Schoon12,
  13. N A van der Gaag1,
  14. M G H Besselink1,
  15. P Fockens2,
  16. T M van Gulik1,
  17. E A J Rauws2,
  18. O R C Busch1,
  19. D J Gouma1
  1. 1Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands
  2. 2Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
  3. 3Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, The Netherlands
  4. 4Department of Gastroenterology and Hepatology, Maasstad Hospital, Rotterdam, The Netherlands
  5. 5Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands
  6. 6Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
  7. 7Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands
  8. 8Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands
  9. 9Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands
  10. 10Department of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands
  11. 11Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
  12. 12Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, The Netherlands
  1. Correspondence to J A M G Tol, Department of Surgery, Academic Medical Center, Meibergdreef 9, Amsterdam AZ 1105, The Netherlands; j.tol{at}amc.uva.nl

Abstract

Introduction In pancreatic cancer, preoperative biliary drainage (PBD) increases complications compared with surgery without PBD, demonstrated by a recent randomised controlled trial (RCT). This outcome might be related to the plastic endoprosthesis used. Metal stents may reduce the PBD-related complications risk.

Methods A prospective multicentre cohort study was performed including patients with obstructive jaundice due to pancreatic cancer, scheduled to undergo PBD before surgery. This cohort was added to the earlier RCT (ISRCTN31939699). The RCT protocol was adhered to, except PBD was performed with a fully covered self-expandable metal stent (FCSEMS). This FCSEMS cohort was compared with the RCT’s plastic stent cohort. PBD-related complications were the primary outcome. Three-group comparison of overall complications including early surgery patients was performed.

Results 53 patients underwent PBD with FCSEMS compared with 102 patients treated with plastic stents. Patients’ characteristics did not differ. PBD-related complication rates were 24% in the FCSEMS group vs 46% in the plastic stent group (relative risk of plastic stent use 1.9, 95% CI 1.1 to 3.2, p=0.011). Stent-related complications (occlusion and exchange) were 6% vs 31%. Surgical complications did not differ, 40% vs 47%. Overall complication rates for the FCSEMS, plastic stent and early surgery groups were 51% vs 74% vs 39%.

Conclusions For PBD in pancreatic cancer, FCSEMS yield a better outcome compared with plastic stents. Although early surgery without PBD remains the treatment of choice, FCSEMS should be preferred over plastic stents whenever PBD is indicated.

Trial registration number: Dutch Trial Registry (NTR3142).

  • ABDOMINAL SURGERY
  • PANCREAS
  • ADENOCARCINOMA

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.